CHINA MARKET ACCESS & REIMBURSEMENT STRATEGY
Market access has gained considerable attention worldwide as countries try to contain their escalating healthcare expenditures amidst the global economic slowdown. There is an increasing need to establish market access functions, especially in emerging markets, where the complex, dynamic healthcare landscape confounds product approval and uptake. Moreover, emerging markets are the engines of growth today, especially China, for which playing more and more critical role in the global economy. Thus, having a presence and good performance in these markets is critical for the majority of pharmaceutical companies.
To address the challenges posed by regulatory agencies and diverse stakeholders, we provide a customized reimbursement strategies and strong support for the market access in China with specific tools and tactics including a partnership with local databases, connections with multiple stakeholders as well as local policy interpretation and project experiences.